Research News

Transcriptional repression by a secondary DNA binding surface of DNA topoisomerase I safeguards against hypertranscription

A team of scientists, led by N2CR member Dr. Tee Wee Wei, has identified the enzyme DNA topoisomerase I (TOP1) as a key regulator of gene activity crucial for normal development and health. Their discovery reveals that a specific disease-associated mutation (R548Q) in TOP1 accelerates gene activity, disrupting normal developmental programs. Tight control of gene activity is essential, as dysregulation can contribute to diseases, particularly in aggressive cancers characterized by transcriptional overdrive. Importantly, the mutation does not impact TOP1’s primary enzymatic function but hinders its ability to bind to DNA correctly. This research highlights TOP1 as a molecular rheostat, ensuring precise control of gene activity levels and maintaining appropriate total transcription levels in our cells.

Read more here: https://www.nature.com/articles/s41467-023-42078-9

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. …

Read More →
Research News

PHF2 regulates genome topology and DNA replication in neural stem cells via cohesion

When a cell divides to make new cells, it needs to copy its DNA so that each new cell has …

Read More →
Research News

METTL8 links mt-tRNA m3C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity

Glioblastoma is the most common and lethal form of adult brain cancer. The presence of cancer stem cells (so-called glioma …

Read More →